Cancer Care Network of South Texas
San Antonio, Texas, United States
Doctor in San Antonio, Texas
2130 NE Interstate 410 Loop # 100, San Antonio, TX 78217
About Cancer Care Network of South Texas
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
3
Favrille
1
Millennium Pharmaceuticals, Inc.
1
Novartis Pharmaceuticals
1
OncoMed Pharmaceuticals, Inc.
1
SOTIO a.s.
1
Clinical Trials at Cancer Care Network of South Texas
During the past decade, Cancer Care Network of South Texas conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on
average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
2004-07-01
Terminated
Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone
2007-06-01
2013-03-01
Completed
502
Extension Study of Idelalisib in Participants With Chronic Lymphocytic Leukemia (CLL) Who Participated in GS-US-312-0116 (NCT01539512)
2012-10-03
2018-06-29
Terminated
161
A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
2012-04-01
2014-04-01
Completed
220
Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies
2013-03-14
2020-01-30
Terminated
326
A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Etoposide and Platinum Therapy
2012-01-07
2017-05-08
Terminated
172
Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer
2014-05-26
2020-01-28
Completed
1,182
Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer
2017-06-20
2020-03-09
Completed
54
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Cancer Care Network of South Texas" #1 sponsor was "Gilead Sciences" with 3 trials, followed by "Favrille" with 1 trials
sponsored, "Millennium Pharmaceuticals, Inc." with 1 trials sponsored, "Novartis Pharmaceuticals" with 1 trials sponsored and "OncoMed Pharmaceuticals, Inc."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
Clinical Trials Conditions at Cancer Care Network of South Texas
According to Clinical.Site data, the most researched conditions in "Cancer Care Network of South Texas" are
"Chronic Lymphocytic Leukemia" (3 trials), "Breast Cancer" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials), "Follicular Lymphoma" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Cancer Care Network of South Texas" in a lesser frequency.
Clinical Trials Intervention Types at Cancer Care Network of South Texas
Most popular intervention types in "Cancer Care Network of South Texas" are "Drug" (6 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Idelalisib" (2 trials), "Adjuvant endocrine therapy" (1 trials), "Bortezomib" (1 trials) and "Cisplatin or Carboplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Cancer Care Network of South Texas
The vast majority of trials in "Cancer Care Network of South Texas" are
7 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Cancer Care Network of South Texas
Currently, there are NaN active trials in "Cancer Care Network of South Texas".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Cancer Care Network of South Texas,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Cancer Care Network of South Texas, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".